Cargando…
A (relatively) risky business: the link between prostatic radiotherapy and second malignancies
Unlikely to change therapeutic decisions for most men with high grade prostate cancer
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4775868/ https://www.ncbi.nlm.nih.gov/pubmed/26935234 http://dx.doi.org/10.1136/bmj.i1073 |
_version_ | 1782419072819920896 |
---|---|
author | Eyler, Christine E Zietman, Anthony L |
author_facet | Eyler, Christine E Zietman, Anthony L |
author_sort | Eyler, Christine E |
collection | PubMed |
description | Unlikely to change therapeutic decisions for most men with high grade prostate cancer |
format | Online Article Text |
id | pubmed-4775868 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BMJ Publishing Group Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-47758682016-03-10 A (relatively) risky business: the link between prostatic radiotherapy and second malignancies Eyler, Christine E Zietman, Anthony L BMJ Editorials Unlikely to change therapeutic decisions for most men with high grade prostate cancer BMJ Publishing Group Ltd. 2016-03-02 /pmc/articles/PMC4775868/ /pubmed/26935234 http://dx.doi.org/10.1136/bmj.i1073 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/. |
spellingShingle | Editorials Eyler, Christine E Zietman, Anthony L A (relatively) risky business: the link between prostatic radiotherapy and second malignancies |
title | A (relatively) risky business: the link between prostatic radiotherapy and second malignancies |
title_full | A (relatively) risky business: the link between prostatic radiotherapy and second malignancies |
title_fullStr | A (relatively) risky business: the link between prostatic radiotherapy and second malignancies |
title_full_unstemmed | A (relatively) risky business: the link between prostatic radiotherapy and second malignancies |
title_short | A (relatively) risky business: the link between prostatic radiotherapy and second malignancies |
title_sort | (relatively) risky business: the link between prostatic radiotherapy and second malignancies |
topic | Editorials |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4775868/ https://www.ncbi.nlm.nih.gov/pubmed/26935234 http://dx.doi.org/10.1136/bmj.i1073 |
work_keys_str_mv | AT eylerchristinee arelativelyriskybusinessthelinkbetweenprostaticradiotherapyandsecondmalignancies AT zietmananthonyl arelativelyriskybusinessthelinkbetweenprostaticradiotherapyandsecondmalignancies AT eylerchristinee relativelyriskybusinessthelinkbetweenprostaticradiotherapyandsecondmalignancies AT zietmananthonyl relativelyriskybusinessthelinkbetweenprostaticradiotherapyandsecondmalignancies |